# PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention

> **NCT07449247** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University Eye Hospital** · enrollment: 233 (estimated)

## Conditions studied

- Pre-myopia

## Interventions

- **DRUG:** 0.01% Atropine

## Key facts

- **NCT ID:** NCT07449247
- **Lead sponsor:** Tianjin Medical University Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 233 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07449247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07449247, "PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07449247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*